New injection aims to shed fluid fast in heart failure patients
NCT ID NCT07318103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an injectable drug called HRS-9057 in 153 adults hospitalized with heart failure who have fluid retention. The main goal is to see if the drug reduces weight (a sign of fluid loss) by day 8 compared to a placebo. Researchers will also check safety and whether patients need extra diuretics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLUID RETENTION CAUSED BY HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100037, China